JAMES MALLETTE: Open Payments
NPI 1811965718 · FLORENCE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$303 in 14 payments from 6 companies in 2025. Trend: 2023 $154 · 2024 $108 · 2025 $303
Food & beverage: $303
| Company | Payments | Amount |
|---|---|---|
| ARS Pharmaceuticals Operations, Inc. | 4 | $85 |
| Novartis Pharmaceuticals Corporation | 4 | $79 |
| Regeneron Healthcare Solutions, Inc. | 3 | $76 |
| GENZYME CORPORATION | 1 | $34 |
| ABBVIE INC. | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: DUPIXENT, NEFFY, Rhapsido, XOLAIR, VRAYLAR, TRELEGY ELLIPTA.
Industry payments across AL — which companies pay providers there.
